Pharmaceutical News

RSS

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of all products produced by Med Prep Consulting Inc. of Tinton Falls, N.J, a specialty pharmacy licensed by the state of New Jersey.

19 Mar 2013

Generic drugmaker liability question to be argued Tuesday before the High Court

The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design.

19 Mar 2013

BUSM awarded funding to provide opioid prescribing education to health care providers

Awarded the first of its kind funding to provide FDA-mandated opioid prescribing education, Boston University School of Medicine has launched a program to train health care providers how to safely and effectively manage patients with chronic pain using opioid analgesics.

19 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

2 in 5 parents believe HPV vaccine is unnecessary

A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo Clinic and others shows.

18 Mar 2013

Supreme Court slated to hear legal arguments regarding generic drug liability question

Generic drugs are supposed to be identical to the brand names that preceded them. And by law, they have to have identical warnings and labels.

16 Mar 2013

Study shows promising benefit of combination therapy in CRPC patients

Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.

16 Mar 2013

Eye health can be possible through nutrition and supplements, say experts

Eating healthy can affect more than what the scale says. According to experts at the University of Alabama at Birmingham, it is possible to aid eye health through nutrition and supplements.

16 Mar 2013

Study finds increased use of antipsychotic medication among Medicaid-insured children

A new study from the University of Maryland found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages two to 17.

16 Mar 2013

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.

15 Mar 2013

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch (UTMB).

15 Mar 2013

Case Western Reserve University receives grant to research on glucose-responsive insulin

Case Western Reserve University's School of Medicine has received a nearly $1 million grant from The Leona M. and Harry B. Helmsley Charitable Trust's Type 1 diabetes program.

15 Mar 2013

Prescribing attention-boosting drugs for healthy kids is misguided

The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided.

14 Mar 2013

Varicella vaccine prevents hospital admission, saves lives

The widespread introduction of a chicken pox vaccine in Australia in 2006 has prevented thousands of children from being hospitalized with severe chicken pox and saved lives, according to new research.

14 Mar 2013

Phase 1b study of olesoxime initiated in multiple sclerosis (MS) patients

...

14 Mar 2013

UNM scientists identify chemical compound that appears to control cell metastases

It's the spread of the original cancer tumor that kills most people. That's why cancer researchers vigorously search for drugs that can prevent metastases, the spread of cancer. The research team co-led by Angela Wandinger-Ness, PhD, and Larry Sklar, PhD, at the University of New Mexico Cancer Center has found a chemical compound that appears to control cell migration and adhesion, two important characteristics of metastatic cancer cells.

14 Mar 2013

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.

14 Mar 2013

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.

14 Mar 2013

Researchers show vitamin D supplementation may help African-Americans lower blood pressure

High blood pressure, a risk factor for heart attacks, heart failure and stroke, is 40 percent more common in African-Americans than in other American ethnic groups.

14 Mar 2013

Pharmaceutical News

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

Generic drugmaker liability question to be argued Tuesday before the High Court

BUSM awarded funding to provide opioid prescribing education to health care providers

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

2 in 5 parents believe HPV vaccine is unnecessary

Supreme Court slated to hear legal arguments regarding generic drug liability question

Study shows promising benefit of combination therapy in CRPC patients

Eye health can be possible through nutrition and supplements, say experts

Study finds increased use of antipsychotic medication among Medicaid-insured children

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Case Western Reserve University receives grant to research on glucose-responsive insulin

Prescribing attention-boosting drugs for healthy kids is misguided

Varicella vaccine prevents hospital admission, saves lives

Phase 1b study of olesoxime initiated in multiple sclerosis (MS) patients

UNM scientists identify chemical compound that appears to control cell metastases

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Researchers show vitamin D supplementation may help African-Americans lower blood pressure

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News